A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis

Recruiting now

Conditions studied: Interstitial Lung Disease

In brief

The goal of this observational study is to learn about risk of progressive pulmonary fibrosis (PPF). The main questions it aims to answer are: * Risk factors of PPF * Prevalence of PPF * Mortality of PPF Patients with interstitial lung disease (ILD) of known or unknown etiology other than IPF who has radiological evidence of pulmonary fibrosis will enroll in this study. * All participants will have baseline investigations at the first visit having provided informed consent. * At the first visit, baseline characteristics will be collected including demographics, medical history, smoking history, complications and medication use. 50 mL of blood will be obtained. High resolution computed tomography (HRCT), full lung function tests and a 6 min walk test will be performed. * Further visits at 6 months and 12 months will include further 50 mL blood sampling. HRCT, full lung function tests and a 6 min walk test will be repeated.

Key facts

Study ID: NCT05895409
Run by: Qianfoshan Hospital
People needed: 610
Starts: 2023-07-27
Expected to finish: 2028-06-01
Last updated by the study team: 2023-11-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

18-80 years old
Agree and sign the informed consent form
Interstitial lung disease patients with imaging features of pulmonary fibrosis

You may not qualify if…

Patients with idiopathic pulmonary fibrosis (IPF)
Pregnant or lactating women
mental illness or cognitive impairment
participating in other clinical studies
Unable to sign informed consent form

Where it is running

The First Affiliated Hospital of Shandong First Medical University — Jinan, Shandong, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.